| |
Group I (N = 10)
|
Group II (N = 27)
|
p value
|
|---|
|
Operative time (min)
|
262 ± 46
|
300 ± 57
|
0.044
|
|
CPB time (min)
|
145 ± 25
|
135 ± 28
|
0.281
|
|
Cross-clamp time (min)
| |
84 ± 19
|
0.120
|
|
VF time (min)
|
90 ± 7
| | |
|
Reperfusion time after declamp (min)
| |
27 ± 8
|
0.038
|
|
after cardioversion (min)
|
33 ± 8
| | |
|
Minimum BT (°C)
|
27.7 ± 1.4
|
33.7 ± 1.5
|
< 0.0001
|
|
Inotropic agent support
|
2 (20.0%)
|
6 (22.2%)
|
1.000
|
|
Maximum CK
|
740.8 ± 436.4
|
591.5 ± 452.3
|
0.266
|
|
CK-MB (IU/L)
|
35.0 ± 10.7
|
60.5 ± 64.9
|
0.155
|
|
Maximum GOT (IU/L)
|
77.0 ± 17.5
|
80.7 ± 50.3
|
0.320
|
- CPB, cardiopulmonary bypass; VF, ventricular fibrillation; BT, body temperature; CK, creatine.
- kinase; GOT, glutamic oxaloacetic transaminase.
